They tell you your levels are fine.
Your blood work says everything is okay.
But your brain disagrees.
A study out of UCSF suggests we have been measuring Vitamin B12 all wrong. Or at least. Not well enough. For years, doctors used a single threshold to define “normal.” If your number sat above the line. You were good. Healthy. Safe.
That threshold might be killing your neurons.
The Lie of “Normal”
The research, published in Annals of Neurology, looked at healthy older adults. People without dementia. Without diagnosed cognitive impairment. They seemed fine.
Until the scans showed up.
The team looked at active B12. Not just total B12 floating around in the blood. But the biologically usable kind. The kind the body can actually get to work. Even when their total levels were considered normal by standard US guidelines. Lower active B12 was linked to slower thinking. Slower visual processing. Visible injury to the white matter.
White matter? It’s the wiring. The cables that let different parts of your brain talk to each other.
If those cables fray. You think slower.
“Normal B12 May Not Always Mean optimal”
Ari J. Green, MD. The senior author. He runs departments of Neurology and Ophthalmlogy at UCSF. He sees this as a blind spot. The current minimum for deficiency. It’s too high. It misses the subtle decay happening before the big lights start flashing.
“We may have missed functional manifestations,” Green says. Clear deficiencies cause anemia. Yes. But what about the quiet erosion?
231 Brains. One Warning.
They tested 231 people. Average age. 71.
None had dementia.
Their average blood B12? 414.8 pmol/mL.
The US cutoff for deficiency is 148 pmol/mL.
That’s a massive gap. These people were statistically safe.
But look at the active levels.
Look at the brain MRIs.
The people with lower active B12 took longer to react to visual stimuli. Their signaling efficiency was down. The MRI scans showed larger volumes of white matter lesions. Scars on the brain. Linked to dementia. Linked to stroke risk.
The effect got worse with age. Older adults are fragile here. Their absorption fails. Their stomachs don’t pick it up like they used to. Medications help nothing. Vegetarian diets? A risk factor.
So. Take the Pill?
Don’t get ahead of yourself.
Alexandra Beaudry-Richard. Co-first author. She suggests we rethink who needs supplementation.
“Even if levels are within normal limits,” she says.
But here’s the twist.
New evidence complicates this.
A 2025 review called B12 deficiency a “modifiable risk factor.” Good to know. Another meta-analysis in 2025? It found a very small benefit to cognitive function when supplementing with B vitamins. The benefit exists. But it’s tiny. Not a brain boost. Not a magic pill.
And another study using Mendelian randomization?
It found no clear evidence that genetically higher total serum B12 protects the general population.
Total serum though. Not active B12. Different beast entirely.
The Message
We don’t know yet if low active B12 causes the decline.
We don’t know if giving pills to everyone saves brains.
What we do know is this: the test we are using. It is blunt.
It misses people whose brains are struggling while the report says “normal.”
Is that comforting? Or terrifying?
For now.
Check your labels.
Ask for the active form if your symptoms persist.
But don’t assume a normal number means you’re invincible.
The wire can rot from the inside out.
Authors: Ahmed Abdelhak, Alexandra Beaudry-Richar, Ari J. Green.
Funding: Westridge Foundation. Canadian Institutes of Health and Resarch. No conflicts.
